Technical Analysis for IGMS - IGM Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 9.34 | -5.94% | -0.59 |
IGMS closed down 5.94 percent on Wednesday, May 8, 2024, on 76 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 10
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| NR7 | Range Contraction | -5.94% | |
| Narrow Range Bar | Range Contraction | -5.94% | |
| Multiple of Ten Bearish | Other | -5.94% | |
| Inside Day | Range Contraction | -5.94% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 15 hours ago |
| 10 DMA Support | about 16 hours ago |
| Down 5% | about 17 hours ago |
| Fell Below 10 DMA | about 17 hours ago |
| Down 3% | about 17 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.7 |
| 52 Week Low | 3.81 |
| Average Volume | 263,628 |
| 200-Day Moving Average | 8.52 |
| 50-Day Moving Average | 9.71 |
| 20-Day Moving Average | 8.80 |
| 10-Day Moving Average | 9.47 |
| Average True Range | 0.87 |
| RSI (14) | 50.98 |
| ADX | 13.76 |
| +DI | 31.92 |
| -DI | 28.01 |
| Chandelier Exit (Long, 3 ATRs) | 7.87 |
| Chandelier Exit (Short, 3 ATRs) | 8.99 |
| Upper Bollinger Bands | 10.83 |
| Lower Bollinger Band | 6.76 |
| Percent B (%b) | 0.63 |
| BandWidth | 46.20 |
| MACD Line | 0.09 |
| MACD Signal Line | -0.15 |
| MACD Histogram | 0.2368 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.27 | ||||
| Resistance 3 (R3) | 10.31 | 10.04 | 10.12 | ||
| Resistance 2 (R2) | 10.04 | 9.81 | 10.02 | 10.07 | |
| Resistance 1 (R1) | 9.69 | 9.66 | 9.56 | 9.65 | 10.01 |
| Pivot Point | 9.42 | 9.42 | 9.36 | 9.40 | 9.42 |
| Support 1 (S1) | 9.07 | 9.19 | 8.94 | 9.03 | 8.67 |
| Support 2 (S2) | 8.80 | 9.04 | 8.78 | 8.61 | |
| Support 3 (S3) | 8.45 | 8.80 | 8.56 | ||
| Support 4 (S4) | 8.41 |
